The markets opened mixed with the Dow slipping 5 points to 21,569 after Congress failed to pass its healthcare bill. Nasdaq gained 19 points to 6,363.
On the upside
Morgan Stanley (NYSE: MS) reported higher second quarter earnings that topped analyst estimates.
Vertex Pharmaceuticals (Nasdaq: VRTX) reported upbeat results from Phase 1 and Phase 2 studies its cystic fibrosis treatment.
Discovery Communications (Nasdaq: DISCA) and Scripps Networks Interactive (Nasdaq: SNI) are discussing a possible merger.
On the downside
McCormick & Co. (NYSE: MKC) will pay approximately $4.2 billion to acquire the food unit of Reckitt Benckiser Group.
IBM (NYSE: IBM) disappointed with lower second quarter earnings and revenue.
CSX (Nasdaq: CSX) reported higher second quarter earnings that beat expectations but the company forecast full year earnings below estimates.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 rose 3 points to 2,463. Bitcoin slipped $3 to $2306.
